Abstract
P1494
Introduction: To explore the value of 18F-FDG PET/MR systemic imaging in detecting liver metastasis of breast cancer.
Methods: The PET/MR and PET/CT imaging of 78 cases of liver metastasis were analyzed retrospectively. On the same day, whole body 18F-FDG PET/CT imaging and PET/MR imaging were performed, taking pathological and clinical diagnosis as the gold standard to compare the differences in the lesions.
Results: 78 patients with liver cancer, a total of 106 intrahepatic metastasis lesions, PET/MR detected all lesions, and PET/CT detected 69 lesions, with significant statistical differences (P<0.01). Among them, 25 lesions were PET-MR positive, while PET-CT was negative; and 19 other lesions were negative for both equipment PET intake. Compared with PET/CT, PET/MR changed the diagnostic results of 28 (35.9%) patients.
Conclusions: The detection rate of PET/MR for breast cancer liver metastasis is significantly better than that of PET/CT.